Prescient Therapeutics Health Care
Cancer Therapeutics

$0.081 0.002 (2.53%)

High $0.09	Low $0.08	Trades 83	Turnover $220,412	Volume 2,818,974
30 June 2023 at 4:10pm

If you were already registered, log in here.

Market Cap (12-Nov) $70,918,696 (780th)	Close (30-Jun) $0.081 0 (0%)	Volume (30-Jun) 2,818,974	Shortsold (14-Apr) 10,996 (0.00%) (617th)
52w High $0.125	52w Low $0.047	P/E 5.48	EPS -0.01
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 2+

Short Interest

ASIC data, 14 Apr 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

617th

of 717 shorted ASX stocks

Peak Short

0.61%

Jan 2020

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	PTX PTX Ann: Application for quotation of securities - PTX
	1 (current) 2 3
	PTX PTX Ann: Two PTX abstracts accepted at prestigious ISCT conference
	PTX PTX Ann: Initial Director's Interest Notice
	PTX PTX Ann: Notification regarding unquoted securities - PTX
	PTX PTX Ann: Experienced Pharma Executive Joins Prescient Board
	PTX PTX Ann: Notification of cessation of securities - PTX
	PTX PTX Ann: Change of Director's Interest Notices x3
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Notice
	PTX PTX Ann: March 2023 Quarterly Update and Appendix 4C
	PTX PTX Ann: Change of Director's Interest Notices x2
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Exercise and Expiry of Listed Options
	PTX PTX Ann: Continued promising results in PTX-100 TCL trial
	PTX PTX Ann: FDA grants broader orphan drug status to PTX100 for TCLs
	PTX PTX Ann: Revised Securities Trading Policy
	PTX PTX Ann: Appendix 4D and Half Year Financial Report
	PTX PTX Ann: Notification of Expiry of Listed Options
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: December 2022 Quarterly Update and Appendix 4C
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Change of Director's Interest Notice
	PTX PTX Ann: Notification of cessation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Notice
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Results of Annual General Meeting
	PTX PTX Ann: AGM Presentation
	PTX PTX Ann: Chair's Address to the 2022 Annual General Meeting
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX Investor presentation and additional patient response
	PTX PTX Ann: September 2022 Quarterly Update and Appendix 4C
	PTX PTX Ann: Notice of Annual General Meeting/Proxy Form
	PTX PTX Ann: PTX-100 Trial Update
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Section 708A Cleansing Notice
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Change of Director's Interest Notices x2
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: Proposed issue of securities - PTX
	PTX PTX Ann: Placement Results
	PTX PTX Ann: SPP Results and Placement
	PTX PTX Ann: Trading Halt
	PTX PTX Ann: Extension of Share Purchase Plan
	PTX PTX Ann: CellPryme-A Investor Presentation
	PTX PTX Ann: PTX unveils CellPryme-A to boost CAR-T performance
	PTX PTX Ann: Prescient unveiling CellPryme-A at CAR-TCR summit in Boston
	PTX PTX Ann: Application for quotation of securities - PTX
	PTX PTX Ann: PTX strategic collaboration with MD Anderson Cancer Center

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

Upcoming Floats (8)

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Capability X

CX8

MATRIX CRITICAL MINERALS LIMITED

MTX $12m raise

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Top

End of Day Prices

Date	Close	Volume	Change
12-Nov	$0.06	1,237,419	+0.00 (1.61%)
11-Nov	$0.06	575,214	+0.00 (3.33%)
10-Nov	$0.06	397,216	+0.00 (7.14%)
09-Nov	$0.06	264,067	+0.00 (3.70%)
06-Nov	$0.05	266,748	+0.00 (1.89%)
05-Nov	$0.05	149,755	+0.00 (3.92%)
04-Nov	$0.05	141,578	0.00 (3.77%)
03-Nov	$0.05	49,214	+0.00 (6.00%)
02-Nov	$0.05	240,332	0.00 (5.66%)
30-Oct	$0.05	191,792	0.00 (3.64%)
29-Oct	$0.06	17,580	+0.00 (5.77%)
28-Oct	$0.05	457,731	0.00 (3.70%)
27-Oct	$0.05	271,970	+0.00 (5.88%)
26-Oct	$0.05	1,589,874	0.00 (5.56%)
23-Oct	$0.05	886,759	0.00 (3.57%)
9 up, 6 down, and 0 flat days

Prescient Therapeutics Health Care Cancer Therapeutics

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Prescient Therapeutics Health Care
Cancer Therapeutics